Trial Profile
A trial of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate (STRIBILD®) in Patients Treated during Primary HIV Infection Compared to Recent HIV Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 01 Mar 2016 New trial record